Clinical Trials on Osteoarthritis Thumb Base Joint in Hungary

Total 35 results

Petz Aladar County Teaching Hospital

Completed

The Effects of Tiszasüly and Kolop Mud-pack Therapy in Knee Osteoarthritis

Knee Osteoarthritis

Hungary
University of Pecs
Gyirmót Sport & Wellness Hotel

Not yet recruiting

Therapeutic Effect of the Natural Mineral Water of the Well B-308 OKK in Győr (Gyirmót) on Knee Osteoarthrosis

Knee Osteoarthritis

Hungary
University of Pecs

Completed

Muscle Activation in Knee Osteoarthritis

Knee Osteoarthritis

Hungary
Petz Aladar County Teaching Hospital

Unknown

Effects of Various Types of Ultrasound Therapy in Hip Osteoarthritis

Hip Osteoarthritis

Hungary
Szeged University

Unknown

Postural Control in Degenerative and Inflammatory Diseases of the Hip (PCHOAI)

Hip Osteoarthritis | Hip Arthritis

Hungary
University of Pecs

Completed

End-range Mobilization on Pressure Pain Threshold

Knee Osteoarthritis

Hungary
University of Pecs

Completed

End-range Mobilization on Time Curve of Pressure Pain Threshold

Knee Osteoarthritis

Hungary
Polyclinic of the Hospitaller Brothers of St. John...

Completed

Clinical Efficacy and Safety of Loxacon Dietary Supplement Capsules at Patients With Knee Arthrosis

Osteo Arthritis Knee

Hungary
Orthox Limited
Avania B.V.

Terminated

FibroFix Cartilage P Knee Implant Study (FFLEX)

Osteoarthritis, Knee

United Kingdom, Hungary
University of Pecs

Completed

End-range Mobilization on Knee Osteoarthritis

Osteo Arthritis Knee

Hungary
University of Pecs

Completed

Effect of Combined Interventions on Pressure Pain Threshold

Osteo Arthritis Knee

Hungary
Anika Therapeutics, Inc.

Completed

Study of Cingal for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide at 39 Weeks Follow up (Cingal17-02)

Knee Osteoarthritis

Hungary, Poland
Anika Therapeutics, Inc.

Completed

Repeat Injection of Cingal® for Osteoarthritis of the Knee

Osteoarthritis of the Knee

Czechia, Hungary, Poland
Anika Therapeutics, Inc.

Completed

Study of Cingal™ for the Relief of Knee Osteoarthritis Compared to Triamcinolone Hexacetonide

Knee Osteoarthritis

Hungary, Poland
Novartis

Completed

Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis (OA)

Osteoarthritis

Czech Republic, Germany, Finland, Hungary, Australia, Austria, Turkey, Poland, Israel, Spain, South Africa, Slovakia, Sweden, Netherlands, New Zealand
Anika Therapeutics, Inc.

Completed

Cingal Study for Knee Osteoarthritis

Knee Osteoarthritis

Czechia, Hungary, Poland, Bulgaria, Canada
Novartis Pharmaceuticals

Active, not recruiting

A Safety and Efficacy Study of Anti-inflammatory (Canakinumab) and Cartilage Stimulating (LNA043) Drugs Injected Into the Knee Joint of Participants With Knee Osteoarthritis (OA)

Knee Osteoarthritis

United States, Hungary, Estonia, Poland, Czechia, Latvia
UCB Pharma

Terminated

Trial to Assess Efficacy and Safety of Lacosamide in Subjects With Osteoarthritis of the Knee

Osteoarthritis

Poland, Germany, Romania, Hungary, United Kingdom, Sweden, Czechia
IBSA Institut Biochimique SA

Completed

A Study to Evaluate the Clinical Performance and Safety of an Intra-articular Hyaluronic Acid in Knee Osteoarthritis

Knee Osteoarthritis

Poland, Germany, Italy, Belgium, Hungary
Procter and Gamble

Completed

Efficacy and Safety of PG-530742 in the Treatment of Mild to Moderate Knee Osteoarthritis

Osteoarthritis, Knee

Hungary, United Kingdom
Novartis Pharmaceuticals

Recruiting

Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis

Symptomatic Knee Osteoarthritis

United States, Spain, Hungary, Argentina, Germany, Slovakia, Czechia, Belgium, Romania
Ono Pharmaceutical Co. Ltd

Terminated

A Study to Evaluate ONO-4474 in Patients With Pain Due to Osteoarthritis of the Knee (MOTION)

Pain | Osteoarthritis, Knee

Poland, Hungary, Spain, Denmark, United Kingdom
Cartiheal (2009) Ltd

Active, not recruiting

Agili-C™ Implant Performance Evaluation

Cartilage or Osteochondral Defects in the Knee | Up to Moderate Osteoarthritis

United States, Israel, Belgium, Italy, Serbia, Hungary, Poland, Romania
Pfizer

Completed

A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee (ITIC)

Osteoarthritis

United States, Argentina, Czech Republic, Slovakia, Spain, Belgium, Canada, Peru, Germany, Hungary, Australia, Italy, Poland, Russian Federation
Mundipharma Research GmbH & Co KG

Completed

OXN PR Compared to OxyPR to Demonstrate Non-inferiority in Pain & Locomotor Function & Improvement in Symptoms of Constipation in OA Subjects

Chronic Osteoarthritis

Spain, Belgium, Finland, Czechia, Germany, Hungary
Pfizer
Eli Lilly and Company

Completed

Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee.

Osteoarthritis, Knee | Osteoarthritis, Hip

Spain, Poland, Hungary, France, Germany, United Kingdom, Japan, Romania, Italy, Austria, Slovakia, Sweden, Bulgaria, Finland, Portugal
Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

A Study Comparing 4 Dose Regimens of PLA-695, Naproxen, and Placebo In Subjects With Osteoarthritis Of The Knee

Osteoarthritis

Poland, Spain, Hong Kong, United States, Canada, Hungary, Netherlands, Brazil, Mexico, Argentina
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Completed

A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip (FACT OA1)

Osteoarthritis, Knee | Osteoarthritis, Hip

United States, Poland, Hungary, Spain, Germany, United Kingdom, Denmark, Lithuania, Romania, Russian Federation, South Africa, Ukraine
Regeneron Pharmaceuticals
Teva Pharmaceutical Industries, Ltd.

Completed

Long-Term Safety and Efficacy Study of Fasinumab in Patients With Pain Due to Osteoarthritis (OA) of the Knee or Hip (FACT LTS & OA)

Osteoarthritis of the Knee or Hip

United States, Bulgaria, Chile, Colombia, Denmark, Estonia, Germany, Hong Kong, Hungary, Italy, Lithuania, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Sweden, Ukraine, United Kingdom
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Analgesic Efficacy of ASP7962 in Patients With Pain Due to Osteoarthritis of the Knee (OAK)

Osteoarthritis of the Knee | Chronic Lower Back Pain

Belgium, Czechia, Germany, Hungary, Spain, United Kingdom
Grünenthal GmbH
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee

Pain | Knee Osteoarthritis

Austria, Croatia, Germany, Hungary, Italy, Latvia, Netherlands, Poland, Portugal, Romania, Slovakia, Spain, United Kingdom
Pfizer
Eli Lilly and Company

Completed

Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement

Osteoarthritis

United States, Spain, Australia, Serbia, Germany, Canada, Japan, New Zealand, Hungary, Italy, Sweden, Lithuania, Portugal, Russian Federation, Slovakia
AstraZeneca

Terminated

Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of AZD1386 in Patients With Osteoarthritis (OA) of the Knee (OA19)

Pain

Bulgaria, Poland, Hungary, Finland, Canada, Slovakia, Japan
Janssen Research & Development, LLC

Completed

Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001

Pain | Osteoarthritis

United States, Poland, Canada, Hungary, New Zealand, United Kingdom
Janssen Research & Development, LLC

Completed

Study of Safety, Efficacy of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3007

Pain | Osteoarthritis

United States, Australia, Poland, Korea, Republic of, Canada, Germany, Hungary, Spain, Czechia, Sweden, United Kingdom

Clinical Trials on Osteoarthritis Thumb Base Joint in Hungary

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations